414 related articles for article (PubMed ID: 35673595)
1. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.
Mao J; Li Y; Bian Q; Xuan Y; Li J; Wang Z; Feng S; Liu X; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2022; 17():1285-1298. PubMed ID: 35673595
[TBL] [Abstract][Full Text] [Related]
2. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease.
Li Y; Li JS; Li WW; Li SY; Tian YG; Lu XF; Jiang SL; Wang Y
BMC Complement Altern Med; 2014 Apr; 14():140. PubMed ID: 24766819
[TBL] [Abstract][Full Text] [Related]
4. Seabuckthorn Wuwei Pulvis attenuates chronic obstructive pulmonary disease in rat through gut microbiota-short chain fatty acids axis.
Wang J; Ren C; Jin L; Batu W
J Ethnopharmacol; 2023 Oct; 314():116591. PubMed ID: 37146846
[TBL] [Abstract][Full Text] [Related]
5. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD.
Zhao P; Yang L; Li J; Li Y; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2016; 11():553-66. PubMed ID: 27042044
[TBL] [Abstract][Full Text] [Related]
6. Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease.
Mao J; Li Y; Feng S; Liu X; Tian Y; Bian Q; Li J; Hu Y; Zhang L; Ji H; Li S
Front Pharmacol; 2020; 11():587176. PubMed ID: 33390958
[TBL] [Abstract][Full Text] [Related]
7. Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD.
Zhao P; Li J; Li Y; Tian Y; Yang L; Li S
Biomed Res Int; 2017; 2017():7091087. PubMed ID: 28424787
[TBL] [Abstract][Full Text] [Related]
8. Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.
Dong Y; Li Y; Sun Y; Mao J; Yao F; Tian Y; Wang L; Li L; Li S; Li J
BMC Complement Altern Med; 2015 Mar; 15():51. PubMed ID: 25888379
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Qingyi Decoction in Severe Acute Pancreatitis-Associated Acute Lung Injury via Gut Microbiota: Targeting the Short-Chain Fatty Acids-Mediated AMPK/NF-κB/NLRP3 Pathway.
Wang Z; Liu J; Li F; Ma S; Zhao L; Ge P; Wen H; Zhang Y; Liu X; Luo Y; Yao J; Zhang G; Chen H
Microbiol Spectr; 2023 Aug; 11(4):e0366422. PubMed ID: 37338348
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease.
Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y
Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936
[TBL] [Abstract][Full Text] [Related]
11. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma signaling.
Li Y; Tian YG; Li JS; Dong YQ; Wang MH; Feng SX; Li LL; Mao J; Wang LL; Luo S
J Ethnopharmacol; 2016 Dec; 193():354-361. PubMed ID: 27562320
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu‑Fei Jian‑Pi.
Li J; Yang L; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X
Mol Med Rep; 2015 Feb; 11(2):1324-33. PubMed ID: 25370181
[TBL] [Abstract][Full Text] [Related]
13. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
[TBL] [Abstract][Full Text] [Related]
14. Yanning Syrup ameliorates the lipopolysaccharide-induced inflammation: Adjusting the gut microbiota, short-chain fatty acids, and the CD4
Wei D; Ma P; Fan Q; Yu H; Peng Y; Li X
J Ethnopharmacol; 2022 Jan; 283():114729. PubMed ID: 34634365
[TBL] [Abstract][Full Text] [Related]
15. [
Wu D; Wang X; Gao Y; Tong J; Yang Q; Ding H; Zhang L; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1500-1508. PubMed ID: 37814864
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-dependent modulation of pre-metastatic niches by Jianpi Yangzheng decoction in the prevention of lung metastasis of gastric cancer.
Zhu X; Zhang X; Shen J; Zheng S; Li H; Han B; Zhang C; Chen M; Sun Q; Wu J
Phytomedicine; 2024 Jun; 128():155413. PubMed ID: 38513377
[TBL] [Abstract][Full Text] [Related]
17. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
[TBL] [Abstract][Full Text] [Related]
18. Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation.
Qin Y; Zhai J; Yang J; Li H; Tian Y; Liu X; Zhao P; Li J
Biomed Pharmacother; 2023 Dec; 168():115614. PubMed ID: 37862971
[TBL] [Abstract][Full Text] [Related]
19. Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats.
Tian Y; Li Y; Li J; Xie Y; Wang M; Dong Y; Li L; Mao J; Wang L; Luo S
BMC Complement Altern Med; 2015 Aug; 15():266. PubMed ID: 26253241
[TBL] [Abstract][Full Text] [Related]
20. Disordered GPR43/NLRP3 expression in peripheral leukocytes of patients with atrial fibrillation is associated with intestinal short chain fatty acids levels.
Fang C; Zuo K; Liu Z; Xu L; Yang X
Eur J Med Res; 2024 Apr; 29(1):233. PubMed ID: 38622672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
